Biomarker Technologies Market by Product (Consumables, and Instruments), Technology (Polymerase Chain Reaction (PCR), Next Generation Sequencing (NGS), Immunoassay, and Others), and Application (Drug Discovery, Diagnostics, and Personalized Medicine), and Indication (Cancer, Infectious Diseases, Autoimmune Disorders, Cardiovascular Disorders, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026

 The biomarker technologies market accounted for $21,594 million in 2018, and is expected to reach $58,508 million by 2026, registering a CAGR of 13.2% from 2019 to 2026.

Biomarker is a biological marker, which indicates a substance or a physical event. These indicated substances or events can be measured and the measurements can be further used for the detection of diseases, a physiological change, response to a treatment and a psychological condition. Biomarker technologies are different techniques, which are employed for testing various diseases. These technologies employ the use of different products to measure a biomarker. Reagents and assays are used in various biomarker technologies such as next generation sequencing, polymerase chain reaction, and others. These biomarker technologies are used in various fields of science such as drug discovery, diagnostics, and personalized medicine. Majorly biomarkers are used to detect diseases such as cancer, infectious diseases, autoimmune diseases, neurological disorders, and others.

Rise in prevalence of various diseases such as autoimmune diseases, cancers, and infectious disease boosts the growth of this market. In addition, the rise in research related to drug discovery, increase in healthcare expenditure, and surge in use of personalized medicine are some other factors that contribute toward the growth of this market. The rise in awareness toward the need of early detection of various diseases such as cancers and high growth potential in emerging economies is anticipated to provide lucrative opportunities in the market during the forecast period. However, high initial investment required for biomarker discovery restricts the growth of the biomarker technologies market.

The biomarker technologies market is segmented based on product, technology, application, indication, and region to provide a detailed assessment of the market. Based on product, the market is divided into consumables, and instruments. The consumables segment is further bifurcated into reagents and assays. Based on technology, the market is divided into polymerase chain reaction, next generation sequencing, immunoassays, and others. On the basis of application, the market is classified into drug discovery, diagnostics and personalized medicine. Based on indication, the market is divided into cancer, infectious diseases, autoimmune disorders, cardiovascular disorders, and others. Based on region, the biomarker technologies market size is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

ü The study provides an in-depth analysis of the global biomarker technologies market along with the current trends and future estimations to elucidate the imminent investment pockets.

ü A quantitative analysis from 2018 to 2026 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.

ü In-depth analysis of biomarker technologies such as polymerase chain reaction, next generation sequencing, immunoassay and others is carried out in the report.

ü The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global market.

KEY MARKET SEGMENTS

By Product

• Consumables

o Assay

o Reagent

• Instruments

By Technology

• Polymerase Chain Reaction (PCR)

• Next Generation Sequencing (NGS)

• Immunoassay

• Others

By Application

• Drug Discovery

• Diagnostics

• Personalized Medicine

By Indication

• Cancer

• Infectious Diseases

• Autoimmune Disorders

• Cardiovascular Disorders

• Others

By Region

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

• Asia-Pacific

o India

o China

o Japan

o Australia

o South Korea

o Rest of Asia-Pacific

• LAMEA

o Brazil

o South Africa

o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Agilent Technologies, Inc.

• Bio-Rad Laboratories, Inc.

• F. Hoffmann-La Roche AG

• Illumina, Inc.

• LI-COR, Inc.

• Merck KGAA

• PERKINELMER INC.

• QIAGEN

• Shimadzu Corporation

• Thermo Fisher Scientific, Inc.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

• Eurofins Scientific

• Enzo Biochem, Inc.

• EKF Diagnostics Holdings plc

• Myriad Genetics, Inc. (Myriad RBM.).

• Becton, Dickinson and Company

CHAPTER 1: INTRODUCTION

1.1. Report description

1.2. Key market segments

1.2.1. List of key players profiled in the report

1.3. Research methodology

1.3.1. Primary research

1.3.2. Secondary research

1.3.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY

2.2. Key findings

2.2.1. Top impacting factors

2.2.2. Top investment pockets

2.3. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key Forces Shaping Biomarker technologies Industry/Market

3.2.1. Moderate bargaining power of supplier

3.2.2. Low bargaining power of buyers

3.2.3. Low threat of substitutes

3.2.4. High intensity of rivalry

3.2.5. Low threat of new entrant

3.3. Pricing Analysis

3.3.1. Pricing Analysis of Biomarker technologies, By Region, 2018 & 2025

3.4. Market evolution/Industry roadmap

3.5. Value Chain Analysis

3.6. Impact of government regulations on global biomarker technologies market

3.7. Industry Pain point analysis

3.8. Market dynamics

3.8.1. Drivers

3.8.1.1. Rise in prevalence of various diseases

3.8.1.2. Surge in R&D activities in healthcare coupled with rise in adoption of early toxicity testing

3.8.1.3. Advantages offered by biomarker in drug development

3.8.1.4. Increase in genome mapping programs

3.8.2. Restraints

3.8.2.1. High initial capital investments required for biomarker discovery

3.8.2.2. Lack of awareness regarding the use of biomarker technologies

3.8.3. Opportunity

3.8.3.1. High potential of the emerging economies

3.8.4. Impact Analyses

CHAPTER 4: BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT AND SERVICES

4.1. Overview

4.2. Consumables

4.2.1. Key market trends, growth factors and opportunities

4.2.2. Market size and forecast, by type

4.2.2.1. Reagents

4.2.2.1.1. Market size and forecast

4.2.2.2. Assays

4.2.2.2.1. Market size and forecast

4.2.3. Market size and forecast, by region

4.2.4. Market analysis by country

4.3. Instruments

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market analysis by country

CHAPTER 5: BIOMARKER TECHNOLOGIES MARKET, BY TECHNOLOGY

5.1. Overview

5.2. Polymerase Chain Reaction (PCR)

5.2.1. Market size and forecast, by region

5.2.2. Market analysis by country

5.3. Next Generation Sequencing (NGS)

5.3.1. Market size and forecast, by region

5.3.2. Market analysis by country

5.4. Immunoassay

5.4.1. Market size and forecast, by region

5.4.2. Market analysis by country

5.5. Others

5.5.1. Market size and forecast, by region

5.5.2. Market analysis by country

CHAPTER 6: BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION

6.1. Overview

6.2. Drug Discovery

6.2.1. Market size and forecast, by region

6.2.2. Market analysis by country

6.3. Diagnostics

6.3.1. Market size and forecast, by region

6.3.2. Market analysis by country

6.4. Personalized Medicine

6.4.1. Market size and forecast, by region

6.4.2. Market analysis by country

CHAPTER 7: BIOMARKER TECHNOLOGIES MARKET, BY INDICATION

7.1. Overview

7.2. Cancer

7.2.1. Market size and forecast, by region

7.2.2. Market analysis by country

7.3. Infectious Diseases

7.3.1. Market size and forecast, by region

7.3.2. Market analysis by country

7.4. Autoimmune Disorders

7.4.1. Market size and forecast, by region

7.4.2. Market analysis by country

7.5. Cardiovascular Disorders

7.5.1. Market size and forecast, by region

7.5.2. Market analysis by country

7.6. Others

7.6.1. Market size and forecast, by region

7.6.2. Market analysis by country

CHAPTER 8: BIOMARKER TECHNOLOGIES MARKET, BY REGION

8.1. Overview

8.2. North America

8.2.1. Key market trends and opportunities

8.2.2. Market analysis by country

8.2.2.1. U.S.

8.2.2.1.1. U.S. market size and forecast, by product and services

8.2.2.1.2. U.S. market size and forecast, by technology

8.2.2.1.3. U.S. market size and forecast, by application

8.2.2.1.4. U.S. market size and forecast, by indication

8.2.2.2. Canada

8.2.2.2.1. Canada market size and forecast, by product and services

8.2.2.2.2. Canada market size and forecast, by technology

8.2.2.2.3. Canada market size and forecast, by application

8.2.2.2.4. Canada market size and forecast, by indication

8.2.2.3. Mexico

8.2.2.3.1. Mexico market size and forecast, by product and services

8.2.2.3.2. Mexico market size and forecast, by technology

8.2.2.3.3. Mexico market size and forecast, by application

8.2.2.3.4. Mexico market size and forecast, by indication

8.2.3. North America market size and forecast, by product and services

8.2.4. North America market size and forecast, by technology

8.2.5. North America market size and forecast, by application

8.2.6. North America market size and forecast, by indication

8.3. Europe

8.3.1. Key market trends and opportunities

8.3.2. Market analysis by country

8.3.2.1. Germany

8.3.2.1.1. Germany market size and forecast, by product and services

8.3.2.1.2. Germany market size and forecast, by technology

8.3.2.1.3. Germany market size and forecast, by application

8.3.2.1.4. Germany market size and forecast, by indication

8.3.2.2. France

8.3.2.2.1. France market size and forecast, by product and services

8.3.2.2.2. France market size and forecast, by technology

8.3.2.2.3. France market size and forecast, by application

8.3.2.2.4. France market size and forecast, by indication

8.3.2.3. UK

8.3.2.3.1. UK market size and forecast, by product and services

8.3.2.3.2. UK market size and forecast, by technology

8.3.2.3.3. UK market size and forecast, by application

8.3.2.3.4. UK market size and forecast, by indication

8.3.2.4. Italy

8.3.2.4.1. Italy market size and forecast, by product and services

8.3.2.4.2. Italy market size and forecast, by technology

8.3.2.4.3. Italy market size and forecast, by application

8.3.2.4.4. Italy market size and forecast, by indication

8.3.2.5. Spain

8.3.2.5.1. Spain market size and forecast, by product and services

8.3.2.5.2. Spain market size and forecast, by technology

8.3.2.5.3. Spain market size and forecast, by application

8.3.2.5.4. Spain market size and forecast, by indication

8.3.2.6. Rest of Europe

8.3.2.6.1. Rest of Europe market size and forecast, by product and services

8.3.2.6.2. Rest of Europe market size and forecast, by technology

8.3.2.6.3. Rest of Europe market size and forecast, by application

8.3.2.6.4. Rest of Europe market size and forecast, by indication

8.3.3. Europe market size and forecast, by product and services

8.3.4. Europe market size and forecast, by technology

8.3.5. Europe market size and forecast, by application

8.3.6. Europe market size and forecast, by indication

8.4. Asia-Pacific

8.4.1. Key market trends and opportunities

8.4.2. Market analysis by country

8.4.2.1. Japan

8.4.2.1.1. Japan market size and forecast, by product and services

8.4.2.1.2. Japan market size and forecast, by technology

8.4.2.1.3. Japan market size and forecast, by application

8.4.2.1.4. Japan market size and forecast, by indication

8.4.2.2. China

8.4.2.2.1. China market size and forecast, by product and services

8.4.2.2.2. China market size and forecast, by technology

8.4.2.2.3. China market size and forecast, by application

8.4.2.2.4. China market size and forecast, by indication

8.4.2.3. Australia

8.4.2.3.1. Australia market size and forecast, by product and services

8.4.2.3.2. Australia market size and forecast, by technology

8.4.2.3.3. Australia market size and forecast, by application

8.4.2.3.4. Australia market size and forecast, by indication

8.4.2.4. India

8.4.2.4.1. India market size and forecast, by product and services

8.4.2.4.2. India market size and forecast, by technology

8.4.2.4.3. India market size and forecast, by application

8.4.2.4.4. India market size and forecast, by indication

8.4.2.5. South Korea

8.4.2.5.1. South Korea market size and forecast, by product and services

8.4.2.5.2. South Korea market size and forecast, by technology

8.4.2.5.3. South Korea market size and forecast, by application

8.4.2.5.4. South Korea market size and forecast, by indication

8.4.2.6. Rest of Asia-Pacific

8.4.2.6.1. Rest of Asia-Pacific market size and forecast, by product and services

8.4.2.6.2. Rest of Asia-Pacific market size and forecast, by technology

8.4.2.6.3. Rest of Asia-Pacific market size and forecast, by application

8.4.2.6.4. Rest of Asia-Pacific market size and forecast, by indication

8.4.3. Asia-Pacific market size and forecast, by product and services

8.4.4. Asia-Pacific market size and forecast, by technology

8.4.5. Asia-Pacific market size and forecast, by application

8.4.6. Asia-Pacific market size and forecast, by indication

8.5. LAMEA

8.5.1. Key market trends and opportunities

8.5.2. Market analysis by country

8.5.2.1. Brazil

8.5.2.1.1. Brazil market size and forecast, by product and services

8.5.2.1.2. Brazil market size and forecast, by technology

8.5.2.1.3. Brazil market size and forecast, by application

8.5.2.1.4. Brazil market size and forecast, by indication

8.5.2.2. Saudi Arabia

8.5.2.2.1. Saudi Arabia market size and forecast, by product and services

8.5.2.2.2. Saudi Arabia market size and forecast, by technology

8.5.2.2.3. Saudi Arabia market size and forecast, by application

8.5.2.2.4. Saudi Arabia market size and forecast, by indication

8.5.2.3. South Africa

8.5.2.3.1. South Africa market size and forecast, by product and services

8.5.2.3.2. South Africa market size and forecast, by technology

8.5.2.3.3. South Africa market size and forecast, by application

8.5.2.3.4. South Africa market size and forecast, by indication

8.5.2.4. Rest of LAMEA

8.5.2.4.1. Rest of LAMEA market size and forecast, by product and services

8.5.2.4.2. Rest of LAMEA market size and forecast, by technology

8.5.2.4.3. Rest of LAMEA market size and forecast, by application

8.5.2.4.4. Rest of LAMEA market size and forecast, by indication

8.5.3. LAMEA market size and forecast, by product and services

8.5.4. LAMEA market size and forecast, by technology

8.5.5. LAMEA market size and forecast, by application

8.5.6. LAMEA market size and forecast, by indication

CHAPTER 9: COMPETITIVE LANDSCAPE

9.1. INTRODUCTION

9.1.1. MARKET PLAYER POSITIONING, 2018

9.2. MARKET SHARE ANALYSIS OF TOP PLAYERS, 2018 (%)

9.3. TOP WINNING STRATEGIES

9.4. COMPETITIVE DASHBOARD

9.5. COMPETITIVE HEATMAP

10.1. AGILENT TECHNOLOGIES, INC.

10.1.1. Company overview

10.1.2. Company snapshot

10.1.3. Operating business segments

10.1.4. Product type Portfolio

10.1.5. Business performance

10.2. BIO-RAD LABORATORIES, INC.

10.2.1. Company overview

10.2.2. Company snapshot

10.2.3. Operating business segments

10.2.4. Product type Portfolio

10.2.5. Business performance

10.2.6. Key strategic moves and developments

10.3. F. HOFFMANN-LA ROCHE LTD.

10.3.1. Company overview

10.3.2. Company snapshot

10.3.3. Operating business segments

10.3.4. Product portfolio

10.3.5. Business performance

10.3.6. Key strategic moves and developments

10.4. Illumina, Inc.

10.4.1. Company overview

10.4.2. Company snapshot

10.4.3. Operating business segments

10.4.4. Product Portfolio

10.4.5. Business performance

10.5. LI-COR, Inc.

10.5.1. Company overview

10.5.2. Company snapshot

10.5.3. Operating business segments

10.5.4. Product portfolio

10.6. Merck KGAA

10.6.1. Company overview

10.6.2. Company snapshot

10.6.3. Operating business segments

10.6.4. Product portfolio

10.6.5. Business performance

10.6.6. Key strategic moves and developments

10.7. PERKINELMER INC.

10.7.1. Company overview

10.7.2. Company snapshot

10.7.3. Operating business segments

10.7.4. Product Portfolio

10.7.5. Business performance

10.8. QIAGEN N.V.

10.8.1. Company overview

10.8.2. Company snapshot

10.8.3. Product type portfolio

10.8.4. Business performance

10.9. Shimadzu Corporation

10.9.1. Company overview

10.9.2. Company snapshot

10.9.3. Operating business segments

10.9.4. Product portfolio

10.9.5. Business performance

10.11. Thermo Fisher Scientific, Inc.

10.11.1. Company overview

10.11.2. Company snapshot

10.11.3. Operating business segments

10.11.4. Product Portfolio

10.11.5. Business performance

10.12. Other Key Player Profile

10.12.1. Key player snapsho

LIST OF TABLES

TABLE 01. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT AND SERVICES, 2018-2026 ($MILLION)

TABLE 02. BIOMARKER TECHNOLOGIES CONSUMBALES MARKET, BY TYPE 2018–2025 ($MILLION)

TABLE 03. BIOMARKER TECHNOLOGIES CONSUMABLES MARKET, BY REGION, 2017–2025 ($MILLION)

TABLE 04. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR CELL CULTURE, BY REGION 2018–2025($MILLION)

TABLE 05. BIOMARKER TECHNOLOGIES SERVICES MARKET, BY REGION 2018–2025($MILLION)

TABLE 06. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY TECHNOLOGY, 2018-2026 ($MILLION)

TABLE 07. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR POLYMERASE CHAIN REACTION, BY REGION 2018–2025($MILLION)

TABLE 08. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR NEXT GENERATION SEQUENCING, BY REGION 2018–2025($MILLION)

TABLE 09. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR IMMUNOASSAY, BY REGION 2018–2025($MILLION)

TABLE 10. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR OTHERS, BY REGION 2018–2025($MILLION)

TABLE 11. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION, 2018-2026 ($MILLION)

TABLE 12. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR DRUG DISCOVERY, BY REGION 2018–2025($MILLION)

TABLE 13. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR DIAGNOSTICS, BY REGION 2018–2025($MILLION)

TABLE 14. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR PERSONALIZED MEDICINE, BY REGION 2018–2025($MILLION)

TABLE 15. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY INDICATION, 2018-2026 ($MILLION)

TABLE 16. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR CANCER, BY REGION 2018–2025($MILLION)

TABLE 17. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR INFECTIOUS DISEASES, BY REGION 2018–2025($MILLION)

TABLE 18. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR AUTOIMMUNE DISORDERS, BY REGION 2018–2025($MILLION)

TABLE 19. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR CARDIOVASCULAR DISORDERS, BY REGION 2018–2025($MILLION)

TABLE 20. BIOMARKER TECHNOLOGIES MARKET REVENUE FOR OTHERS, BY REGION 2018–2025($MILLION)

TABLE 21. NORTH AMERICA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY COUNTRY 2019–2026 ($MILLION)

TABLE 22. U.S. BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 23. U.S. BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 24. U.S. BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 25. U.S. BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 26. CANADA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 27. CANADA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 28. CANADA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 29. CANADA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 30. MEXICO BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 31. MEXICO BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 32. MEXICO BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 33. MEXICO BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 34. NORTH AMERICA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026($MILLION)

TABLE 35. NORTH AMERICA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECHNOLOGY 2019–2026($MILLION)

TABLE 36. NORTH AMERICA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026($MILLION)

TABLE 37. NORTH AMERICA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026($MILLION)

TABLE 38. EUROPE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY COUNTRY 2019–2026 ($MILLION)

TABLE 39. GERMANY BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 40. GERMANY BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 41. GERMANY BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 42. U.S. BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 43. FRANCE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 44. FRANCE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 45. FRANCE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 46. FRANCE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 47. UK BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 48. UK BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 49. UK BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 50. UK BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 51. ITALY BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 52. ITALY BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 53. ITALY BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 54. ITALY BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 55. SPAIN BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 56. SPAIN BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 57. SPAIN BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 58. SPAIN BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 59. REST OF EUROPE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 60. REST OF EUROPE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 61. REST OF EUROPE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 62. REST OF EUROPE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 63. EUROPE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026($MILLION)

TABLE 64. EUROPE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECHNOLOGY 2019–2026($MILLION)

TABLE 65. EUROPE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026($MILLION)

TABLE 66. EUROPE BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026($MILLION)

TABLE 67. ASIA-PACIFIC BIOMARKER TECHNOLOGIES MARKET REVENUE, BY COUNTRY 2019–2026 ($MILLION)

TABLE 68. JAPAN BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 69. JAPAN BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 70. JAPAN BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 71. JAPAN BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 72. CHINA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 73. CHINA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 74. CHINA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 75. CHINA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 76. AUSTRALIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 77. AUSTRALIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 78. AUSTRALIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 79. AUSTRALIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 80. INDIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 81. INDIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 82. INDIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 83. INDIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 84. SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 85. SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 86. SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 87. SOUTH KOREA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 88. REST OF ASIA-PACIFIC BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 89. REST OF ASIA-PACIFIC BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 90. REST OF ASIA-PACIFIC BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 91. REST OF ASIA-PACIFIC BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 92. ASIA-PACIFIC BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026($MILLION)

TABLE 93. ASIA-PACIFIC BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECHNOLOGY 2019–2026($MILLION)

TABLE 94. ASIA-PACIFIC BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026($MILLION)

TABLE 95. ASIA-PACIFIC BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026($MILLION)

TABLE 96. LAMEA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY COUNTRY 2019–2026 ($MILLION)

TABLE 97. BRAZIL BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 98. BRAZIL BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 99. BRAZIL BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 100. BRAZIL BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 101. SAUDI ARABIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 102. SAUDI ARABIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 103. SAUDI ARABIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 104. SAUDI ARABIA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 105. SOUTH AFRICA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 106. SOUTH AFRICA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 107. SOUTH AFRICA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 108. SOUTH AFRICA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 109. REST OF LAMEA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026 ($MILLION)

TABLE 110. REST OF LAMEA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECNOLOGY 2019–2026 ($MILLION)

TABLE 111. REST OF LAMEA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026 ($MILLION)

TABLE 112. REST OF LAMEA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026 ($MILLION)

TABLE 113. LAMEA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY PRODUCT AND SERVICES 2019–2026($MILLION)

TABLE 114. LAMEA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY TECHNOLOGY 2019–2026($MILLION)

TABLE 115. LAMEA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY APPLICATION 2019–2026($MILLION)

TABLE 116. LAMEA BIOMARKER TECHNOLOGIES MARKET REVENUE, BY INDICATION 2019–2026($MILLION)

TABLE 117. AGILENT: COMPANY SNAPSHOT

TABLE 118. AGILENT: OPERATING SEGMENTS

TABLE 119. AGILENT: PRODUCT TYPE PORTFOLIO

TABLE 120. BIO-RAD: COMPANY SNAPSHOT

TABLE 121. BIO-RAD: OPERATING SEGMENTS

TABLE 122. BIO-RAD: PRODUCT TYPE PORTFOLIO

TABLE 123. ROCHE: COMPANY SNAPSHOT

TABLE 124. ROCHE: OPERATING SEGMENTS

TABLE 125. ROCHE: PRODUCT TYPE PORTFOLIO

TABLE 126. ILLUMINA: COMPANY SNAPSHOT

TABLE 127. ILLUMINA: OPERATING SEGMENTS

TABLE 128. ILLUMINA: PRODUCT PORTFOLIO

TABLE 129. LI-COR, INC.: COMPANY SNAPSHOT

TABLE 130. LI-COR, INC.: OPERATING SEGMENTS

TABLE 131. LI-COR, INC.: PRODUCT PORTFOLIO

TABLE 132. MERCK: COMPANY SNAPSHOT

TABLE 133. MERCK: OPERATING SEGMENTS

TABLE 134. MERCK: PRODUCT PORTFOLIO

TABLE 135. PERKINELMER: COMPANY SNAPSHOT

TABLE 136. PERKINELMER: OPERATING SEGMENTS

TABLE 137. PERKINELMER: PRODUCT PORTFOLIO

TABLE 138. QIAGEN: COMPANY SNAPSHOT

TABLE 139. QIAGEN: PRODUCT TYPE PORTFOLIO

TABLE 140. SHIMADZU CORPORATION: COMPANY SNAPSHOT

TABLE 141. SHIMADZU CORPORATION: OPERATING SEGMENTS

TABLE 142. SHIMADZU CORPORATION: PRODUCT PORTFOLIO

TABLE 143. THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT

TABLE 144. THERMO FISHER SCIENTIFIC: OPERATING SEGMENTS

TABLE 145. THERMO FISHER SCIENTIFIC: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. EXECUTIVE SUMMARY

FIGURE 02. TOP IMPACTING FACTORS

FIGURE 03. TOP INVESTMENT POCKETS

FIGURE 04. MARKET EVOLUTION/INDUSTRY ROADMAP

FIGURE 05. VALUE CHAIN ANALYSIS

FIGURE 06. IMPACT ANALYSES, BIOMARKERS TECHNOLOGIES MARKET

FIGURE 07. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY PRODUCT AND SERVICES, 2018-2025

FIGURE 08. BIOMARKET TECHNOLOGIES REAGENTS MARKET, 2017–2025 ($MILLION)

FIGURE 09. BIOMARKET TECHNOLOGIES ASSAYS MARKET, 2017–2025 ($MILLION)

FIGURE 10. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES CONSUMABLES MARKET REVENUE FOR BIOPHARMACEUTICALS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR INSTRUMENTS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR SERVICES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 13. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY TECHNOLOGY, 2017-2025

FIGURE 14. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2017 & 2025 (%)

FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR NEXT GENERATION SEQUENCING, BY COUNTRY, 2017 & 2025 (%)

FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR IMMUNOASSAY, BY COUNTRY, 2017 & 2025 (%)

FIGURE 17. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 18. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY APPLICATION, 2017-2025

FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR POLYMERASE CHAIN REACTION, BY COUNTRY, 2017 & 2025 (%)

FIGURE 20. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR DIAGNOSTICS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 21. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR PERSONALIZED MEDICINE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 22. GLOBAL BIOMARKER TECHNOLOGIES MARKET, BY INDICATION, 2017-2025

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR CANCER, BY COUNTRY, 2017 & 2025 (%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2017 & 2025 (%)

FIGURE 25. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR AUTOIMMUNE DISORDERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 26. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR CARDIOVASCULAR DISORDERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 27. COMPARATIVE SHARE ANALYSIS OF BIOMARKER TECHNOLOGIES MARKET FOR OTHERS, BY COUNTRY, 2017 & 2025 (%)

FIGURE 28. MARKET PLAYER POSITIONING, 2018

FIGURE 29. MARKET SHARE ANALYSIS: BIOMARKER TECHNOLOGIES MARKET, 2018 (%)

FIGURE 30. COMPETITIVE DASHBOARD

FIGURE 31. COMPETITIVE HEATMAP OF KEY PLAYERS

FIGURE 32. AGILENT: REVENUE, 2016–2018 ($MILLION)

FIGURE 33. AGILENT: REVENUE SHARE BY OPERATING SEGMENT, 2018 (%)

FIGURE 34. AGILENT: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 35. BIO-RAD: NET SALES, 2015–2017 ($MILLION)

FIGURE 36. BIO-RAD: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 37. BIO-RAD: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 38. ROCHE: NET SALES, 2015–2017 ($MILLION)

FIGURE 39. ROCHE: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 40. ROCHE: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 41. ILLUMINA: REVENUE, 2015–2017 ($MILLION)

FIGURE 42. ILLUMINA: REVENUE SHARE, BY OPERATING SEGMENT, 2017 (%)

FIGURE 43. ILLUMINA: REVENUE SHARE, BY GEOGRAPHY, 2017 (%)

FIGURE 44. MERCK: REVENUE, 2016–2018 ($MILLION)

FIGURE 45. MERCK: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 46. MERCK: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 47. PERKINELMER: NET SALES, 2016–2018 ($MILLION)

FIGURE 48. PERKINELMER: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 49. PERKINELMER: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 50. QIAGEN: NET SALES, 2015–2017 ($MILLION)

FIGURE 51. QIAGEN: REVENUE SHARE BY PRODUCT TYPE, 2017 (%)

FIGURE 52. QIAGEN: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 53. SHIMADZU CORPORATION: NET SALES, 2015–2017 ($MILLION)

FIGURE 54. SHIMADZU CORPORATION: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 55. SHIMADZU CORPORATION: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 56. THERMO FISHER SCIENTIFIC: REVENUE, 2016–2018 ($MILLION)

FIGURE 57. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY SEGMENT, 2018 (%)

FIGURE 58. THERMO FISHER SCIENTIFIC: REVENUE SHARE, BY GEOGRAPHY, 2018 (%